Cancer stem cells and radiotherapy

Research output: Contribution to journalArticle

Abstract

In clinic, tumor recurrence and metastasis are the major barriers to further improve the overall cancer patients’ survival. The theory of tumor repopulation due to radiation described decades ago is being supported by new experimental data. The heterogeneity of cancer cell populations in a given tumor is recently evidenced by the present of cancer stem cells (CSCs) that are different from other non-CSC tumor cells and maintain unique self-renewal and tumor-initiating phenotypes. The CSCs isolated from many human tumors including the breast cancer stem cells (BCSCs) are demonstrated to hold specific characteristics and are demonstrated to be resistant to an array of anti-cancer agents and radiation therapy. In this chapter, a number of prosurvival pathways and biomarkers found in BCSCs will be discussed. Several prosurvival features including CSCs repopulation, DNA repair ability, as well as the HER2- NFjB-HER2 signaling loop in the radioresistant BCSCs will be illustrated. Further clarification of the specific networks associated with the radioresistant phenotype of BCSCs will shed new light on the molecular mechanism of tumor radioresistance, and will help to generate targets to detect and treat therapy-resistant tumor cells.

Original languageEnglish (US)
Pages (from-to)49-57
Number of pages9
JournalMedical radiology
Volume63
DOIs
StatePublished - 2012

Fingerprint

Neoplastic Stem Cells
Radiotherapy
Neoplasms
Breast Neoplasms
Phenotype
DNA Repair
Biomarkers
Radiation
Neoplasm Metastasis
Recurrence
Survival

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Cite this

Cancer stem cells and radiotherapy. / Li, Jian-Jian.

In: Medical radiology, Vol. 63, 2012, p. 49-57.

Research output: Contribution to journalArticle

@article{5a878a30e809452692773d1260a2cdce,
title = "Cancer stem cells and radiotherapy",
abstract = "In clinic, tumor recurrence and metastasis are the major barriers to further improve the overall cancer patients’ survival. The theory of tumor repopulation due to radiation described decades ago is being supported by new experimental data. The heterogeneity of cancer cell populations in a given tumor is recently evidenced by the present of cancer stem cells (CSCs) that are different from other non-CSC tumor cells and maintain unique self-renewal and tumor-initiating phenotypes. The CSCs isolated from many human tumors including the breast cancer stem cells (BCSCs) are demonstrated to hold specific characteristics and are demonstrated to be resistant to an array of anti-cancer agents and radiation therapy. In this chapter, a number of prosurvival pathways and biomarkers found in BCSCs will be discussed. Several prosurvival features including CSCs repopulation, DNA repair ability, as well as the HER2- NFjB-HER2 signaling loop in the radioresistant BCSCs will be illustrated. Further clarification of the specific networks associated with the radioresistant phenotype of BCSCs will shed new light on the molecular mechanism of tumor radioresistance, and will help to generate targets to detect and treat therapy-resistant tumor cells.",
author = "Jian-Jian Li",
year = "2012",
doi = "10.1007/174_2012_648",
language = "English (US)",
volume = "63",
pages = "49--57",
journal = "Medical radiology",
issn = "0942-5373",
publisher = "U. S. Joint Publications Research Service",

}

TY - JOUR

T1 - Cancer stem cells and radiotherapy

AU - Li, Jian-Jian

PY - 2012

Y1 - 2012

N2 - In clinic, tumor recurrence and metastasis are the major barriers to further improve the overall cancer patients’ survival. The theory of tumor repopulation due to radiation described decades ago is being supported by new experimental data. The heterogeneity of cancer cell populations in a given tumor is recently evidenced by the present of cancer stem cells (CSCs) that are different from other non-CSC tumor cells and maintain unique self-renewal and tumor-initiating phenotypes. The CSCs isolated from many human tumors including the breast cancer stem cells (BCSCs) are demonstrated to hold specific characteristics and are demonstrated to be resistant to an array of anti-cancer agents and radiation therapy. In this chapter, a number of prosurvival pathways and biomarkers found in BCSCs will be discussed. Several prosurvival features including CSCs repopulation, DNA repair ability, as well as the HER2- NFjB-HER2 signaling loop in the radioresistant BCSCs will be illustrated. Further clarification of the specific networks associated with the radioresistant phenotype of BCSCs will shed new light on the molecular mechanism of tumor radioresistance, and will help to generate targets to detect and treat therapy-resistant tumor cells.

AB - In clinic, tumor recurrence and metastasis are the major barriers to further improve the overall cancer patients’ survival. The theory of tumor repopulation due to radiation described decades ago is being supported by new experimental data. The heterogeneity of cancer cell populations in a given tumor is recently evidenced by the present of cancer stem cells (CSCs) that are different from other non-CSC tumor cells and maintain unique self-renewal and tumor-initiating phenotypes. The CSCs isolated from many human tumors including the breast cancer stem cells (BCSCs) are demonstrated to hold specific characteristics and are demonstrated to be resistant to an array of anti-cancer agents and radiation therapy. In this chapter, a number of prosurvival pathways and biomarkers found in BCSCs will be discussed. Several prosurvival features including CSCs repopulation, DNA repair ability, as well as the HER2- NFjB-HER2 signaling loop in the radioresistant BCSCs will be illustrated. Further clarification of the specific networks associated with the radioresistant phenotype of BCSCs will shed new light on the molecular mechanism of tumor radioresistance, and will help to generate targets to detect and treat therapy-resistant tumor cells.

UR - http://www.scopus.com/inward/record.url?scp=84929086783&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84929086783&partnerID=8YFLogxK

U2 - 10.1007/174_2012_648

DO - 10.1007/174_2012_648

M3 - Article

AN - SCOPUS:84929086783

VL - 63

SP - 49

EP - 57

JO - Medical radiology

JF - Medical radiology

SN - 0942-5373

ER -